Related Experiment Video

Updated: Jul 12, 2025

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.0K

Corrigendum statement for publication "Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for

Pritam Sadhukhan1, Mousumi Kundu1, Sharmistha Chatterjee1

  • 1Division of Molecular Medicine, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, India.

Biomaterials Advances
|October 28, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.1K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.0K

Related Experiment Videos

Last Updated: Jul 12, 2025

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.0K
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.1K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

Articles linked to this work by shared authors, journal, and citation graph.

A Bioactive Fraction of Euphorbia antiquorum Stem Powder Ameliorates High-Fat High-Fructose Diet/Streptozotocin-Induced Diabetes via GLUT-4 Modulation.

Chemistry & biodiversity·2026

The Association Between Hamstring Tightness and Chronic Low Back Pain: A Comparative Study.

Cureus·2026

Nutraceutical interventions for neuroprotection: a comprehensive review.

Biochemical pharmacology·2025

Insights into the molecular mechanism of neurological diseases and their pathophysiological responses.

Archives of toxicology·2025

Therapeutic Uses of Dietary Organosulfur Compounds in Response to Viral (SARS-CoV-2)/Bacterial Infection, Inflammation, Cancer, Oxidative Stress, Cardiovascular Diseases, Obesity, and Diabetes.

Chemistry & biodiversity·2025

Comparison of Post-operative Functional Outcomes of Intertrochanteric Fractures Treated With Trochanteric Fixation Nail Versus Proximal Femoral Nail.

Cureus·2025

Fe2N@C nanomaterials: Synergistic PTT/CDT/NO for the dynamic therapy of diabetic foot ulcer.

Biomaterials advances·2026

GSH-responsive nanoparticle drug delivery system for simultaneous blockade of CD73/A2AR to reverse adenosine-mediated immunosuppression.

Biomaterials advances·2026

Mucin hydrogel fibers enable oxygen-limited co-culture of Bifidobacterium bifidum and intestinal epithelial cells.

Biomaterials advances·2026

Hydrogen bond-organized β-sheet self-assembling peptide hydrogel integrating rapid hemostasis and wound repair.

Biomaterials advances·2026

Mesoporous silica-coated gold nanorods functionalized with the D3 peptide and loaded with epigallocatechin-3-gallate reduce β-amyloid toxicity in the presence of Zn(II) ions.

Biomaterials advances·2026

Microfluidic engineering of polymer-based drug delivery systems: From particle synthesis to organ-on-a-chip validation and application.

Biomaterials advances·2026

Inhaled Nitric Oxide Therapy and Changes in Pulmonary Artery Pulsatility Index During Venoarterial Extracorporeal Membrane Oxygenation Weaning in Cardiogenic Shock Requiring ECPELLA.

Circulation reports·2026

MutexaGPT: an intuition-to-design translator for physics-based enzyme engineering.

Nature computational science·2026

Spacer-engineered donor DNA enhances CRISPR-Cas9-mediated knockin to establish a chemical knockdown platform for endogenous proteins.

International journal of biological macromolecules·2026

Effect of glass transition temperature on the final morphology of nanoparticle-laden aerosol droplets.

Journal of colloid and interface science·2026

Chitosan-dsRNA improves tissue stability and delivery for RNAi-mediated Varroa destructor control.

Pest management science·2026

Zinc displacement and metabolic interference: cobalt ion-mediated therapy for broad-spectrum CRKP-resistant pneumonia via inhalable microspheres.

Nature communications·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us